Skip to main navigation
Skip to search
Skip to main content
Research Explorer The University of Manchester Home
Home
Profiles
Research units
Research output
Projects
Impacts
Activities
Press/Media
Prizes
Equipment
Datasets
Student theses
Search by expertise, name or affiliation
Strategies in ALK Rearranged NSCLC Patients
Fiona Blackhall
Division of Cancer Sciences (L5)
Research output
:
Chapter in Book/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Strategies in ALK Rearranged NSCLC Patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Crizotinib
100%
Anaplastic Lymphoma Kinase Inhibitor
66%
Lung Cancer
33%
Base
33%